What it's for (Indications)
- Lactobacillus reuteri and Lactobacillus rhamnosus are commonly utilized probiotic strains with documented benefits for various gastrointestinal and, in some cases, genitourinary health conditions.
- Primary indications often include the management and prevention of antibiotic-associated diarrhea (AAD), infectious diarrhea (e.
- g.
- , traveler's diarrhea, acute gastroenteritis in children), and symptoms associated with irritable bowel syndrome (IBS), such as abdominal pain and bloating.
- Additionally, Lactobacillus reuteri has shown promise in reducing crying time in infants with colic, while specific strains of Lactobacillus rhamnosus (e.
- g.
- , GG) are well-researched for supporting immune function, especially in the prevention of respiratory infections and atopic dermatitis.
- In women's health, these strains, particularly Lactobacillus reuteri and Lactobacillus rhamnosus, are frequently incorporated into supplements aimed at restoring and maintaining a healthy vaginal microbiome, thereby aiding in the prevention or adjunctive treatment of bacterial vaginosis and vulvovaginal candidiasis.
- These applications are based on their ability to modulate gut and vaginal flora, exert antimicrobial effects against pathogens, and modulate local immune responses.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The optimal dosage of Lactobacillus reuteri and Lactobacillus rhamnosus can vary significantly depending on the specific strain, the targeted health condition, and the age group. For adults, typical daily dosages range from 1 billion (1 x 10^9) to 50 billion (5 x 10^10) Colony-Forming Units (CFUs) for general gut health, immune support, or to address specific conditions like antibiotic-associated diarrhea. For infants with colic, Lactobacillus reuteri DSM 17938 is often administered at 100 million (1 x 10^8) CFUs per day. In cases of acute infectious diarrhea or for vaginal health, higher dosages might be recommended, sometimes up to 10-20 billion CFUs daily for specific strains. It is crucial to follow the manufacturer's instructions or a healthcare professional's guidance, as efficacy is often strain- and dose-dependent. Probiotics are generally taken orally, often with food or as directed, to enhance survival through the digestive tract and optimize their beneficial effects within the gastrointestinal system. |
Safety & Warnings
Common Side Effects
- Lactobacillus reuteri and Lactobacillus rhamnosus are generally well-tolerated and considered safe for most healthy individuals when consumed at recommended dosages.
- The most commonly reported side effects are mild and transient, primarily affecting the gastrointestinal system.
- These can include temporary abdominal discomfort, bloating, increased gas (flatulence), or a slight change in bowel habits, such as softer stools or mild constipation, as the gut microbiome adjusts to the introduction of new bacteria.
- These symptoms typically resolve within a few days or weeks of continuous use.
- Less commonly, individuals may experience allergic reactions, though these are rare and usually associated with other ingredients in the formulation (e.
- g.
- , dairy, soy, gluten) rather than the bacterial strains themselves.
- Patients with severe underlying conditions, compromised immune systems, or those with central venous catheters may be at higher risk for more serious adverse events, which are addressed in the 'Warnings' and 'Black Box Warning' sections, requiring careful medical consideration.
Serious Warnings
- Black Box Warning: **Serious Warnings: Risk of Sepsis in Vulnerable Populations** While Lactobacillus reuteri and Lactobacillus rhamnosus are generally considered safe in healthy individuals, there is a serious, albeit rare, risk of bacteremia, fungemia, or sepsis in specific vulnerable patient populations. This risk is particularly elevated in individuals who are severely immunocompromised (e.g., severe neutropenia, advanced HIV/AIDS with low CD4 counts, recent organ transplant recipients on high-dose immunosuppressive therapy, or active cancer patients undergoing intensive chemotherapy), critically ill patients (e.g., those in intensive care units, especially with indwelling central venous catheters), or those with severely compromised intestinal barrier integrity (e.g., severe short bowel syndrome, acute hemorrhagic pancreatitis, severe inflammatory bowel disease flares with mucosal damage). Cases of systemic infections with Lactobacillus species have been reported in these high-risk groups, which can lead to life-threatening conditions requiring aggressive medical intervention, including antibiotic therapy and removal of implicated catheters. Healthcare providers should meticulously assess the risk-benefit profile before recommending or administering these probiotics to such patients. Close monitoring for signs of infection (e.g., unexplained fever, chills, new onset hypotension, altered mental status, or changes in laboratory parameters indicative of sepsis) is imperative if probiotics are deemed absolutely necessary in these high-risk individuals. Use in such populations should only occur under strict medical supervision and after careful consideration of the potential for severe adverse outcomes, with immediate discontinuation if any signs of systemic infection emerge.
- While Lactobacillus reuteri and Lactobacillus rhamnosus are generally recognized as safe, certain populations should exercise caution or avoid use without explicit medical supervision.
- Individuals who are severely immunocompromised due to conditions such as HIV/AIDS, active cancer treatment (chemotherapy or radiation), organ transplantation, or those taking high-dose immunosuppressive medications, are at an increased risk of developing bacteremia or fungemia from probiotic organisms.
- Similarly, critically ill patients, especially those with short bowel syndrome, compromised intestinal barriers (e.
- g.
- , severe pancreatitis, severe inflammatory bowel disease flares), or those with central venous catheters, should only use probiotics under strict medical guidance due to the potential for translocation of bacteria into the bloodstream and subsequent systemic infection.
- Patients with a history of prosthetic heart valve endocarditis should also consult a healthcare professional before use.
- Allergic reactions, though rare, can occur, particularly in individuals with severe dairy or soy allergies if the product contains these allergens as culture media components.
- Discontinue use and seek immediate medical attention if severe allergic symptoms, high fever, or persistent, worsening gastrointestinal distress occurs.
How it Works (Mechanism of Action)
The therapeutic benefits of Lactobacillus reuteri and Lactobacillus rhamnosus stem from their multifaceted mechanisms of action within the host gastrointestinal and genitourinary tracts. These probiotic strains exert their effects through several key pathways. Firstly, they engage in competitive exclusion, meaning they effectively compete with pathogenic bacteria for adhesion sites on the intestinal or vaginal epithelium and for available nutrients, thereby inhibiting the growth and colonization of harmful microbes. Secondly, they produce a variety of antimicrobial substances, such as lactic acid, acetic acid, hydrogen peroxide, and specific bacteriocins (e.g., reuterin from L. reuteri), which directly inhibit or kill a wide range of pathogens. Thirdly, these lactobacilli can significantly modulate the host's immune system, both locally and systemically. They interact with immune cells in the gut-associated lymphoid tissue (GALT), influencing cytokine production (e.g., increasing anti-inflammatory cytokines like IL-10 and decreasing pro-inflammatory ones like TNF-α), enhancing intestinal barrier function by promoting tight junction integrity, and stimulating the production of mucin, which further protects the epithelial lining. They also contribute to the fermentation of indigestible carbohydrates, producing short-chain fatty acids (SCFAs) like butyrate, which serve as an energy source for colonocytes and possess anti-inflammatory properties, thereby improving overall gut health and homeostasis.
Commercial Brands (Alternatives)
No other brands found for this formula.